FDA targets federal health officials suspected of misconduct
WASHINGTON Scientists from the Food and Drug Administration have accused federal health officials of “serious misconduct” in a letter to Congress, the New York Times reported Monday.
According to the letter, which the scientists sent to Congress on Oct. 14, officials from the regulatory agency “corrupted the scientific review of medical devises” by ordering scientists to alter their conclusions.
The Times reported that while disputes between officials and scientists over when to allow drugs and devices onto the market have happened before, this case was unusual because so many scientists had signed their names on the letter.
FDA grants conditional approval to generic version of Wyeth’s Effexor
PITTSBURGH The Food and Drug Administration has given tentative approval to a generic version of Wyeth Pharmaceutical’s Effexor XR, an antidepressant.
Mylan announced the FDA decision Monday for its version of the drug, known generically as venlafaxine hydrochloride. Mylan plans to sell the extended-release capsules in 37.5 mg, 75 mg and 150 mg formulations.
The branded version of the drug had sales of $3 billion during the 12 months ending Sept. 30, according to IMS Health.
Interpol seizes more than $6 million in counterfeit prescription drugs in Asia
NEW YORK More than $6 million in counterfeit drugs were seized in an international Interpol sting as part of an investigation lasting five months.
The bust, called Operation Storm, netted $6.65 million in counterfeits of drugs for malaria, HIV and tuberculosis in Singapore, Myanmar, Vietnam, Thailand, Laos, Cambodia and China.
The international law-enforcement agency arrested 27 people in the sting.